Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs Psilocybin

Psilocybin boosts mind perception but doesn’t reduce atheism

by Mane Kara-Yakoubian
September 25, 2024
in Psilocybin
(Photo credit: Adobe Stock)

(Photo credit: Adobe Stock)

Share on TwitterShare on Facebook
Follow PsyPost on Google News

A recent study published in Journal of Psychoactive Drugs found that while psychedelic experiences increased mind perception across various entities, they did not significantly change individuals’ Atheist-Believer status.

The relationship between psychedelics and belief systems has long fascinated researchers, particularly the possibility that psychedelics like psilocybin might alter spiritual or religious beliefs. Previous cross-sectional studies suggested that psychedelic experiences could lead to shifts in metaphysical beliefs or religious identifications, with some participants reporting increased spirituality and reduced atheism after using these substances. However, these earlier studies had various biases, such as relying on retrospective accounts and self-selection among participants already interested in belief changes.

Sandeep M. Nayak and colleagues addressed these limitations by conducting a prospective longitudinal study to assess how psilocybin, a well-known psychedelic, impacts belief systems and mind perception.

The researchers conducted a prospective longitudinal study, recruiting 657 participants who had planned to undergo a psilocybin experience outside of controlled laboratory settings. The recruitment materials did not mention belief changes to avoid priming participants about potential outcomes related to their spiritual or religious views.

Participants were asked to complete surveys at multiple time points: during informed consent (baseline), two weeks before their scheduled psilocybin experience, 2-4 weeks after the experience, and again 2-3 months later. These surveys collected a wide range of data, including demographic information and specifics related to their psilocybin use, such as dosage, setting, and ingestion method, and assessments of mind perception (e.g., attribution of consciousness to various living and non-living entities), metaphysical beliefs (e.g., materialism, dualism), and Atheist-Believer status (non-believer, agnostic, or believer).

The mind perception scale measured participants’ views on the conscious experience of various entities, ranging from non-human animals and plants to inanimate objects like rocks. The metaphysical beliefs scale included items that assessed participants’ views on the nature of reality, such as whether they believed in dualism (the separation of mind and body) or materialism (the belief that all phenomena have a material explanation). The Atheist-Believer scale captured participants’ religious affiliations or spiritual beliefs before and after the psilocybin experience.

The results revealed an increase in participants’ attribution of consciousness to various living and non-living entities following their psilocybin experience, particularly non-human primates, quadrupeds (e.g., dogs and cats), insects, fungi, and plants. These shifts in mind perception were evident both at the 2-4 week follow-up and again at 2-3 months.

Participants who were psychedelic-naive—those experiencing psilocybin for the first time—showed greater increases in mind perception than those with prior psychedelic experience. In contrast, there was little to no change in participants’ metaphysical beliefs; the belief that mind and body are distinct (dualism) or that material phenomena stem from the mind (idealism) remained stable. A small increase in determinism (the belief that events are pre-determined) was observed at the 2-3 month follow-up.

Participants’ Atheist-Believer status also remained unchanged, with no significant shifts in the proportions of non-believers, agnostics, or believers, contradicting earlier studies that suggested psilocybin might increase spirituality or reduce atheism. Overall, the findings suggest that psilocybin’s effect on mind perception is stronger than its influence on core spiritual or philosophical beliefs.

Of note is that this study lacked a non-psychedelic control group, making it harder to distinguish whether the observed changes were specifically due to psilocybin.

The research, “Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study”, was authored by Sandeep M. Nayak, Sydney H. White, Samantha N. Hilbert, Matthew X. Lowe, Heather Jackson, Roland R. Griffiths, Albert Garcia-Romeu, and David B. Yaden.

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

Psilocybin appears to have a uniquely powerful relationship with nature relatedness
Neuroimaging

Psilocybin induces large-scale brain network reorganization, offering insights into the psychedelic state

June 14, 2025

A new study using high-resolution EEG reveals that psilocybin dramatically alters brain connectivity in rats. The psychedelic induced dose-dependent changes in network organization, disrupting normal patterns of neural communication and suggesting rodents may be viable models for studying altered consciousness.

Read moreDetails
Meta-analysis highlights potential of psilocybin therapy for treatment-resistant depression
Depression

Psilocybin therapy shows similar benefits for patients with and without recent antidepressant use

June 11, 2025

A new study finds that individuals with treatment-resistant depression experienced similar improvements from psilocybin-assisted psychotherapy whether or not they had recently discontinued antidepressant medications.

Read moreDetails
Single-dose psilocybin therapy shows promise for veterans with treatment-resistant depression
Psilocybin

21-year-old man dies after jabbing pencil into his brain during psilocybin trip

June 5, 2025

A detailed case report describes how a 21-year-old man died from self-inflicted ocular trauma during a bad psilocybin trip. The tragic event illustrates how rare but extreme reactions to psychedelics can lead to fatal outcomes.

Read moreDetails
Clinical psychologists appear to have cautiously favorable attitudes toward psychedelic-assisted mental health treatments
Psilocybin

Only a specific dose of psilocybin induces lasting antidepressant-like effects, study suggests

May 27, 2025

A recent study found that a single moderate dose of psilocybin produced lasting antidepressant-like effects in rats, while higher doses led to unwanted side effects. The findings highlight the importance of optimal dosing.

Read moreDetails
Psilocybin and escitalopram produce antidepressant effects via distinct brain mechanisms, study suggests
Depression

Psilocybin and escitalopram produce antidepressant effects via distinct brain mechanisms, study suggests

May 25, 2025

A new study using brain scans found that psilocybin and escitalopram reduce depression symptoms through different neural mechanisms. While escitalopram dampened emotional brain activity, psilocybin preserved or slightly increased it, suggesting distinct pathways to recovery.

Read moreDetails
Antidepressants may diminish psilocybin’s effects even after discontinuation
Depression

A single dose of psilocybin might help reduce symptoms in treatment-resistant depression

May 12, 2025

A new open-label study suggests that a single dose of psilocybin, combined with psychological support, may reduce symptoms in people with severe treatment-resistant depression. Improvements were sustained for up to 12 weeks, although effects were weaker in those with PTSD.

Read moreDetails
Psilocybin use has surged in the United States since 2019
Psilocybin

Psilocybin use has surged in the United States since 2019

May 10, 2025

Psilocybin use has surged across the U.S. in recent years, with the biggest increases seen among adults with depression, anxiety, and chronic pain.

Read moreDetails
A dose of psilocybin stirred the brain of a barely conscious woman
Neuroimaging

A dose of psilocybin stirred the brain of a barely conscious woman

May 7, 2025

In a groundbreaking case report, scientists administered psilocybin to a woman in a minimally conscious state and observed increased brain complexity and new spontaneous behavior—offering a glimpse into how psychedelics might influence consciousness in severe brain injury patients.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Neuroscientists discover biological mechanism that helps the brain ignore irrelevant information

Problematic porn use remains stable over time and is strongly linked to mental distress, study finds

Christian nationalists tend to imagine God as benevolent, angry over sins, and engaged

Psilocybin induces large-scale brain network reorganization, offering insights into the psychedelic state

Scientists map how alcohol changes bodily sensations

Poor sleep may shrink brain regions vulnerable to Alzheimer’s disease, study suggests

Narcissists perceive inequity because they overestimate their contributions, study suggests

Fear predicts authoritarian attitudes across cultures, with conservatives most affected

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy